| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association between all-cause mortality and insurance status transition among the elderly population in a rural area in Korea: Kangwha Cohort Study
|
Jang, Sung-In
|
|
2015
|
119 |
5 |
p. 680-687
8 p.
|
artikel
|
| 2 |
Competition among pharmacies and the typology of services delivered: The Portuguese case
|
Martins, Lurdes
|
|
2015
|
119 |
5 |
p. 640-647
8 p.
|
artikel
|
| 3 |
Contents
|
|
|
2015
|
119 |
5 |
p. iv-v
nvt p.
|
artikel
|
| 4 |
Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment
|
Petrou, Panagiotis
|
|
2015
|
119 |
5 |
p. 563-568
6 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2015
|
119 |
5 |
p. iii-
1 p.
|
artikel
|
| 6 |
Estimating community health needs against a Triple Aim background: What can we learn from current predictive risk models?
|
Elissen, Arianne M.J.
|
|
2015
|
119 |
5 |
p. 672-679
8 p.
|
artikel
|
| 7 |
European collaboration on relative effectiveness assessments: What is needed to be successful?
|
Kleijnen, Sarah
|
|
2015
|
119 |
5 |
p. 569-576
8 p.
|
artikel
|
| 8 |
From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management
|
Mossialos, Elias
|
|
2015
|
119 |
5 |
p. 628-639
12 p.
|
artikel
|
| 9 |
How profitable is a voluntary deductible in health insurance for the consumer?
|
van Winssen, K.P.M.
|
|
2015
|
119 |
5 |
p. 688-695
8 p.
|
artikel
|
| 10 |
Price difference as a predictor of the selection between brand name and generic statins in Japan
|
Takizawa, Osamu
|
|
2015
|
119 |
5 |
p. 612-619
8 p.
|
artikel
|
| 11 |
Price elasticities in the German Statutory Health Insurance market before and after the health care reform of 2009
|
Pendzialek, Jonas B.
|
|
2015
|
119 |
5 |
p. 654-663
10 p.
|
artikel
|
| 12 |
Reregulation of the Swedish pharmacy sector—A qualitative content analysis of the political rationale
|
Wisell, Kristin
|
|
2015
|
119 |
5 |
p. 648-653
6 p.
|
artikel
|
| 13 |
Same drugs, valued differently? Comparing comparators and methods used in reimbursement recommendations in Australia, Canada, and Korea
|
Bae, Green
|
|
2015
|
119 |
5 |
p. 577-587
11 p.
|
artikel
|
| 14 |
Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands
|
Duijmelinck, Daniëlle M.I.D.
|
|
2015
|
119 |
5 |
p. 664-671
8 p.
|
artikel
|
| 15 |
The effect of new drug pricing systems and new reimbursement guidelines on pharmaceutical expenditures and prescribing behavior among hypertensive patients in Korea
|
Cho, Mee-Hyun
|
|
2015
|
119 |
5 |
p. 604-611
8 p.
|
artikel
|
| 16 |
The effects of reduced copayments on discontinuation and adherence failure to statin medication in Australia
|
Knott, Rachel J.
|
|
2015
|
119 |
5 |
p. 620-627
8 p.
|
artikel
|
| 17 |
The unintended effects of the Medicare Part D low income subsidy
|
Decarolis, Francesco
|
|
2015
|
119 |
5 |
p. 597-603
7 p.
|
artikel
|
| 18 |
Why orphan drug coverage reimbursement decision-making needs patient and public involvement
|
Douglas, Conor M.W.
|
|
2015
|
119 |
5 |
p. 588-596
9 p.
|
artikel
|
Tijdschrift beschrijving